Streptokinase is indicated for the treatment of AMI, acute massive pulmonary embolism (PE), deep vein thrombosis (DVT), arterial thrombosis, and occluded arteriovenous cannulae.
The global Streptokinase market was valued at US$ 364 million in 2023 and is anticipated to reach US$ 526.1 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
North American market for Strep...
Naloxone drug in this report.
The global Naloxone market was valued at US$ 26800 million in 2023 and is anticipated to reach US$ 33840 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
North American market for Naloxone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-P...
Lansoprazole drug in this report.
The global Lansoprazole market was valued at US$ 362 million in 2023 and is anticipated to reach US$ 541.2 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North American market for Lansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 203...
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
The global Coagulation Factor IX market was valued at US$ 362 million in 2023 and is anticipated to reach US$ 526 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated...
Mycophenolate Mofetil drug in this report.
The global Mycophenolate Mofetil market was valued at US$ 674 million in 2023 and is anticipated to reach US$ 962.1 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Mycophenolate Mofetil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast...
Multiple myeloma drugs fall into various drug classes, including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), alkylating agents, corticosteriods, histone deactylase inhibitors (HDACs), bisphophonates, and monoclonal antibodies (MAbs).
The global Multiple Myeloma Drugs market was valued at US$ 874 million in 2023 and is anticipated to reach US$ 1271.1 million by 2030, witnessing a...
Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, mycobacterium avium complex, leprosy, and Legionnaire's disease. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
The global Rifampicin market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 193 million by 2030, witnes...
Tissue plasminogen activator (abbreviated tPA or PLAT) is a protein involved in the breakdown of blood clots. It is a serine protease found on endothelial cells, the cells that line the blood vessels. As an enzyme, it catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for clot breakdown. Human tPA has a molecular weight of ~70 kDa in the single-chain form.
The global...
MRSA is the result of decades of often unnecessary antibiotic use. For years, antibiotics have been prescribed for colds, flu and other viral infections that don't respond to these drugs.
The global MRSA Antibiotics market was valued at US$ 4055.6 million in 2023 and is anticipated to reach US$ 5316.4 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North American...
Polypeptide antibiotic. Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains. Examples of this class include actinomycin, bacitracin, colistin, and polymyxin B. Actinomycin-D has found use in cancer chemotherapy.
The global Polypeptide Drug market was valued at US$ 689 million in 2023 and is anticipated to rea...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals